1887

Abstract

Early detection of carbapenem-resistant (CREco), categorized as a critical priority pathogen by the World Health Organization (WHO), is crucial in optimizing therapeutic options and to thwart outbreaks in clinical settings.

The need of the hour is a diagnostic method that can detect carbapenem resistance conferred by intrinsic or acquired carbapenem resistance mechanisms or both.

The study investigates the performance of a novel screening chromogenic method for detection of CREco.

Carbapenem-susceptible (=23) and non-susceptible (=90) were used to investigate the efficiency of the blue chromogenic test. All of the isolates were received from a tertiary referral hospital in Silchar, India and subjected to the blue chromogenic test and observed for colour change. A colour change from colourless to blue is interpreted as a positive result. The test results were further compared with available methods for detection of carbapenem resistance conferred by carbapenemase production or other carbapenem resistance mechanisms.

The blue chromogenic test generated 100 % (CI: 95.98–100 %) sensitive and 100 % (CI: 85.75–100 %) specific results for the detection of CREco with no false-positive or false-negative results. Within 3 h after incubation, the test detects all CREco with carbapenemase activity. Additionally, the blue chromogenic test also positively detected harbouring carbapenemase variants and with efflux and porin activity, compared to other phenotypic-based approaches.

The study highlights a novel method that is highly sensitive and specific, inexpensive, rapid and user-friendly for the detection of CREco. With the surge and expansion of CREco, this sensitive, specific, user-friendly and inexpensive method can be used in laboratories with limited facilities for early detection of CREco, thereby improving infection control along with averting future outbreaks.

Funding
This study was supported by the:
  • Indian Council of Medical Research (Award 2020-7955/CMB-BMS dated 09.03.2021)
    • Principle Award Recipient: BhaskarJyoti Das
  • Department of Biotechnology, Ministry of Science and Technology, India (Award BT/PR242/NER/95/716/2017 dated 28.09.2018)
    • Principle Award Recipient: AmitabhaBhattacharjee
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001782
2023-12-19
2024-04-27
Loading full text...

Full text loading...

References

  1. WHO Implementation Manual to Prevent and Control the Spread of Carbapenem-Resistant Organisms at the National and Health Care Facility Level: Interim Practical Manual Supporting Implementation of the Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter Baumannii and Pseudomonas Aeruginosa in Health Care Facilities (No.WHO/UHC/ SDS/2019.6) Geneva, Switzerland: World Health Organization; 2017
    [Google Scholar]
  2. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007; 20:440–458 [View Article] [PubMed]
    [Google Scholar]
  3. Papagiannitsis CC, Študentová V, Izdebski R, Oikonomou O, Pfeifer Y et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry meropenem hydrolysis assay with NH4HCO3, a reliable tool for direct detection of carbapenemase activity. J Clin Microbiol 2015; 53:1731–1735 [View Article] [PubMed]
    [Google Scholar]
  4. Glupczynski Y, Evrard S, Ote I, Mertens P, Huang T-D et al. Evaluation of two new commercial immunochromatographic assays for the rapid detection of OXA-48 and KPC carbapenemases from cultured bacteria. J Antimicrob Chemother 2016; 71:1217–1222 [View Article] [PubMed]
    [Google Scholar]
  5. Soumet C, Ermel G, Fach P, Colin P. Evaluation of different DNA extraction procedures for the detection of Salmonella from chicken products by polymerase chain reaction. Lett Appl Microbiol 1994; 19:294–298 [View Article] [PubMed]
    [Google Scholar]
  6. Das BJ, Wangkheimayum J, Singha KM, Bhowmik D, Dhar (Chanda) D et al. Propagation of blaKPC-2 within two sequence types of Escherichia coli in a tertiary referral hospital of northeast India. Gene Reports 2021; 24:101283 [View Article]
    [Google Scholar]
  7. Das BJ, Singha KM, Wangkheimayum J, Bhowmik D, Chanda DD et al. Occurrence of blaOXA-48 type carbapenemase in Escherichia coli with coexisting resistance determinants: a report from India. Gene Reports 2022; 26:101459 [View Article]
    [Google Scholar]
  8. CLSI Committee The Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; M100-ED32 Wayne, PA: CLSI; 2022
    [Google Scholar]
  9. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM et al. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002; 40:3798–3801 [View Article] [PubMed]
    [Google Scholar]
  10. Tsakris A, Kristo I, Poulou A, Themeli-Digalaki K, Ikonomidis A et al. Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory. J Clin Microbiol 2009; 47:362–367 [View Article] [PubMed]
    [Google Scholar]
  11. Pournaras S, Maniati M, Spanakis N, Ikonomidis A, Tassios PT et al. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity. J Antimicrob Chemother 2005; 56:761–764 [View Article] [PubMed]
    [Google Scholar]
  12. Swick MC, Morgan-Linnell SK, Carlson KM, Zechiedrich L. Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance. Antimicrob Agents Chemother 2011; 55:921–924 [View Article] [PubMed]
    [Google Scholar]
  13. Chetri S, Bhowmik D, Paul D, Pandey P, Chanda DD et al. AcrAB-TolC efflux pump system plays a role in carbapenem non-susceptibility in Escherichia coli. BMC Microbiol 2019; 19:210 [View Article] [PubMed]
    [Google Scholar]
  14. Chetri S, Singha M, Bhowmik D, Nath K, Chanda DD et al. Transcriptional response of OmpC and OmpF in Escherichia coli against differential gradient of carbapenem stress. BMC Res Notes 2019; 12:138 [View Article] [PubMed]
    [Google Scholar]
  15. Dortet L, Agathine A, Naas T, Cuzon G, Poirel L et al. Evaluation of the RAPIDEC® CARBA NP, the Rapid CARB Screen® and the Carba NP test for biochemical detection of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother 2015; 70:3014–3022 [View Article] [PubMed]
    [Google Scholar]
  16. Tamma PD, Opene BNA, Gluck A, Chambers KK, Carroll KC et al. Comparison of 11 phenotypic assays for accurate detection of carbapenemase-producing enterobacteriaceae. J Clin Microbiol 2017; 55:1046–1055 [View Article] [PubMed]
    [Google Scholar]
  17. Merkier AK, Centrón D. bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii. Int J Antimicrob Agents 2006; 28:110–113 [View Article] [PubMed]
    [Google Scholar]
  18. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006; 258:72–77 [View Article] [PubMed]
    [Google Scholar]
  19. Al-Hassan L, El Mehallawy H, Amyes SGB. Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt. Clin Microbiol Infect 2013; 19:1082–1088 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001782
Loading
/content/journal/jmm/10.1099/jmm.0.001782
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error